Form 8-K - Current report:
SEC Accession No. 0001625101-22-000008
Filing Date
2022-02-15
Accepted
2022-02-15 09:26:47
Documents
13
Period of Report
2022-02-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K plse-20220209x8k.htm   iXBRL 8-K 78394
2 EX-99.1 plse-20220209xex99_1.htm EX-99.1 14212
  Complete submission text file 0001625101-22-000008.txt   216168

Data Files

Seq Description Document Type Size
3 EX-101.SCH plse-20220209.xsd EX-101.SCH 2771
4 EX-101.LAB plse-20220209_lab.xml EX-101.LAB 14660
5 EX-101.PRE plse-20220209_pre.xml EX-101.PRE 10501
7 EXTRACTED XBRL INSTANCE DOCUMENT plse-20220209x8k_htm.xml XML 4585
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

EIN.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37744 | Film No.: 22637255
SIC: 3841 Surgical & Medical Instruments & Apparatus